GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures. [PDF]
Barbanti P +28 more
europepmc +1 more source
Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy. [PDF]
Huang Z, Xu M, Zhang W, Song X.
europepmc +1 more source
Homme de 39 ans souffrant d’un bézoard rectal de graines de citrouille. [PDF]
Hussey A, Lee B, Douglas-Vail M.
europepmc +1 more source
Establishing a living biobank of pediatric high-grade glioma and ependymoma suitable for cancer pharmacology. [PDF]
Deligne C +34 more
europepmc +1 more source
Exploratory actor mapping of social interactions within tick risk surveillance networks in France. [PDF]
Zortman I, Vial L, Pollet T, Binot A.
europepmc +1 more source
Patient Education in Spa Resorts: Experience from a French National Program for Patients with Chronic Venous Insufficiency. [PDF]
Carpentier PH, Satger B, Sandrin B.
europepmc +1 more source
Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study. [PDF]
Barbanti P +19 more
europepmc +1 more source
Observation of nanocarbon-growth transition from 1D to 2D morphology through on-naked-insulator plasma processing. [PDF]
Hatakeyama R, Ueno H, Kwon E, Misaizu F.
europepmc +1 more source
The Grain of Vision and the Grain of Attention [PDF]
openaire +1 more source

